ArticleJournal of natural medicines2026
Ogonto, a traditional Japanese herbal medicine, attenuates food allergy symptoms in mice through the induction of regulatory T cells.
Article in Journal of natural medicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Despite the rising prevalence of food allergies (FAs) in recent decades, existing therapeutic drugs remain inadequate. Therefore, the development of novel therapeutic strategies for FAs is urgently needed. Baicalein, a flavonoid from Scutellariae baicalensis, has been reported to ameliorate ovalbumin (OVA)-induced FA responses by inducing regulatory T cells (Tregs) in a mouse model. Here, we examined the effects of five traditional Japanese herbal medicines (Kampo medicines) containing Scutellariae radix on Treg induction and FA responses. All five Kampo medicines significantly enhanced the transcriptional activity of Foxp3, a master regulator of Tregs, in a recombinant human Jurkat cell line transfected with a Foxp3-luciferase reporter. Among them, Ogonto exerted the strongest effect. In addition, Ogonto significantly increased Foxp3 gene expression in Jurkat T cells and upregulated the expression of Ten-eleven translocation 2 (TET2) and TET3, demethylating enzymes that contribute to the stable expression of Foxp3. In our HPLC analysis, the Ogonto preparation used in this study was found to contain baicalin, the glycosylated form of baicalein. We next used an OVA-induced FA mouse model to evaluate the effects of Ogonto administration on allergic symptoms and the proportion of Tregs in the mesenteric lymph nodes (mLNs). Ogonto ameliorated OVA-induced diarrhea and rectal hypothermia and reduced OVA-specific immunoglobulin E levels. Furthermore, Ogonto increased the proportion of CD4⁺Foxp3⁺ Tregs in the mLNs of FA mice. These results suggest that Ogonto suppresses the development of FA by increasing Tregs.
Indexed as
Identifiers
41559499What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.